Delivery Order SPE2DR25D2003-SPE2DR26FQ95K
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Viberzi 100 mg tablets (60-count units) with a ceiling value of $2,755.71. This firm fixed-price delivery order, which will be completed by September 9, 2025, carries no set-aside designation and was competitively awarded. The product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a $2,136.20 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Viberzi 75 mg tablets (60-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 29, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Viberzi 75 mg tablets (60-count units) under a firm fixed-price contract with a ceiling value of $1,707.63. This non-set-aside competitive award represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The place of performance is the contractor's corporate office location in Conshohocken, Pennsylvania, with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Viberzi 100 mg tablets (60-count units) valued at $2,014.42. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a delivery order under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The pharmaceutical product will be delivered to the company's corporate headquarters location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Viberzi 100 mg tablets (60-count packages) with a ceiling value of $3,030.63. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The order is scheduled for completion by June 6, 2025, and will...
- The Defense Logistics Agency awarded a delivery order valued at $1,653.21 to AmerisourceBergen Drug Corp for the supply of Viberzi 100 mg tablets (60-count units) under a firm fixed-price contract type. The award, issued on November 14, 2025, with an ultimate completion date of November 17, 2025, represents a non-competitive delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical products will be delivered to the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $3,524.52 on September 26, 2025, for the supply of Viberzi 100 mg tablets (60-count units). This competitive contract carries a firm fixed price structure with an ultimate completion date of September 29, 2025, and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award utilizes no set-aside designation and represents a child contract under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Viberzi 100 mg tablets (60-count) with a ceiling value of $1,594.88. This firm fixed-price, non-set-aside contract is classified as a delivery order and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 26, 2025. The award represents a single-order transaction under the broader federal...
- The Defense Logistics Agency awarded a $3,689.52 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Viberzi 75 mg tablets (60-count packages). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 29, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Viberzi 75 mg tablets (60-count) with a ceiling value of $2,106.67. This firm fixed-price delivery order, which is expected to be completed by October 29, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The award was made without...
- SPE2DR25D2003Indefinite Delivery Contract
- SPE2DR25D2003-SPE2DR26FQ95KDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Viberzi 100 mg tablets (60-count units) with a ceiling value of $1,652.42. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is set to be completed by November 13, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a critical pharmaceutical distributor for federal medical procurement, AmerisourceBergen supplies a broad range of medications and medical supplies to support military healthcare programs and the Defense Health Agency. The company's federal contract portfolio demonstrates consistent capability in fulfilling competitive procurement requirements across diverse therapeutic domains and transaction values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 11/12/25 |